Endothelium-specific overexpression of human IC53 downregulates endothelial nitric oxide synthase activity and elevates systolic blood pressure in mice

Cardiovasc Res. 2009 Nov 1;84(2):292-9. doi: 10.1093/cvr/cvp204. Epub 2009 Jun 18.

Abstract

Aims: Hypertension is one of the major risk factors for cardiovascular diseases. Endothelial cells (ECs) exert important functions in the regulation of blood pressure. A novel gene, IC53, as an isoform of the cyclin-dependent kinase (CDK)-binding protein gene C53, is mainly expressed in vascular ECs and is upregulated in the failing heart of rats. Overexpression of IC53 promotes proliferation of ECs. To examine whether IC53 plays a role in the regulation of vascular tone and blood pressure, we constructed a transgenic (tg) mouse model of the IC53 gene and studied its phenotypes relevant to vascular function.

Methods and results: IC53 cDNA was cloned from a human aorta cDNA library. Using the endothelium-specific VE-cadherin promoter, we constructed tg mice in which IC53 was specifically overexpressed in vascular endothelia and found that the tg mice exhibit elevated systolic blood pressure (SBP) in contrast to the wild-type (wt) controls. Further studies revealed impaired endothelium-dependent vasodilation, reduced nitric oxide (NO) production and decreased endothelial NO synthase (eNOS) expression, and activity in the tg mice. Inhibition of IC53 in human umbilical vein ECs induces upregulation of eNOS activity.

Conclusion: Our results indicate that IC53 participates in the regulation of vascular homeostasis. Endothelium-specific overexpression of IC53 is associated with elevated SBP, which may be in part attributed to the downregulation of eNOS signalling.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antigens, CD / genetics
  • Blood Pressure* / drug effects
  • Blood Pressure* / genetics
  • Cadherins / genetics
  • Cell Cycle Proteins
  • Cells, Cultured
  • Cloning, Molecular
  • Dose-Response Relationship, Drug
  • Down-Regulation
  • Endothelial Cells / drug effects
  • Endothelial Cells / enzymology*
  • Endothelin-1 / blood
  • Gene Expression Regulation, Enzymologic
  • Genotype
  • Humans
  • Hypertension / enzymology*
  • Hypertension / genetics
  • Hypertension / physiopathology
  • Intracellular Signaling Peptides and Proteins / genetics
  • Intracellular Signaling Peptides and Proteins / metabolism*
  • Mice
  • Mice, Inbred C57BL
  • Mice, Transgenic
  • Nerve Tissue Proteins / genetics
  • Nerve Tissue Proteins / metabolism*
  • Nitric Oxide / blood
  • Nitric Oxide Synthase Type III / genetics
  • Nitric Oxide Synthase Type III / metabolism*
  • Phenotype
  • Promoter Regions, Genetic
  • RNA Interference
  • RNA, Messenger / metabolism
  • Systole
  • Tumor Suppressor Proteins
  • Vasodilation* / drug effects
  • Vasodilation* / genetics
  • Vasodilator Agents / pharmacology

Substances

  • Antigens, CD
  • CDK5RAP3 protein, human
  • Cadherins
  • Cell Cycle Proteins
  • Endothelin-1
  • Intracellular Signaling Peptides and Proteins
  • Nerve Tissue Proteins
  • RNA, Messenger
  • Tumor Suppressor Proteins
  • Vasodilator Agents
  • cadherin 5
  • Nitric Oxide
  • NOS3 protein, human
  • Nitric Oxide Synthase Type III
  • Nos3 protein, mouse